S2Medical AB - Class B

NEW
FRA:S21 (Sweden)   Class B
€ 0.00090 +0.00080 (+800%) Mar 28
At Loss
P/B:
6.39
Market Cap:
€ 821.00K ($ 894.00K)
Enterprise V:
€ 728.00K ($ 792.00K)
Volume:
-
Avg Vol (2M):
1.00K
Trade In:
What is a stock summary page? Click here for an overview.

Business Description

Description
S2Medical AB is a research-intensive MedTech company from Sweden. The company has developed several unique wound care products and has many disruptive technologies in the pipeline. Its products include wound debridment, blood stilling, skin grafting, tissue substitutes, bandage, and antimicrobial.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.65
Interest Coverage 0.47
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.16
Distress
Grey
Safe
Beneish M-Score 0.23
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate -41.9
3-Year Book Growth Rate -58.9

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 47.66
9-Day RSI 49.21
14-Day RSI 49.78
3-1 Month Momentum % -87.5
6-1 Month Momentum % -94.74
12-1 Month Momentum % -97.94

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.9
Quick Ratio 0.84
Cash Ratio 0.16
Days Inventory 771.78
Days Sales Outstanding 51.57
Days Payable 608.61

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -126.1
Shareholder Yield % -51.75

Financials (Next Earnings Date:2025-05-16 Est.)

FRA:S21's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

S2Medical AB Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.933
EPS (TTM) (€) -0.001
Beta -3.11
3-Year Sharpe Ratio 0.48
3-Year Sortino Ratio 3.25
Volatility % 293.08
14-Day RSI 49.78
14-Day ATR (€) 0.001367
20-Day SMA (€) 0.00084
12-1 Month Momentum % -97.94
52-Week Range (€) 0.0001 - 0.0085
Shares Outstanding (Mil) 844.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

S2Medical AB Filings

Filing Date Document Date Form
No Filing Data

S2Medical AB Stock Events

Financials Calendars
Event Date Price (€)
No Event Data

S2Medical AB Frequently Asked Questions

What is S2Medical AB(FRA:S21)'s stock price today?
The current price of FRA:S21 is €0.00. The 52 week high of FRA:S21 is €0.01 and 52 week low is €0.00.
When is next earnings date of S2Medical AB(FRA:S21)?
The next earnings date of S2Medical AB(FRA:S21) is 2025-05-16 Est..
Does S2Medical AB(FRA:S21) pay dividends? If so, how much?
S2Medical AB(FRA:S21) does not pay dividend.

Press Release

Subject Date
No Press Release